CoChat

An Interaction between RRP6 and SU(VAR)3-9 Targets RRP6 to Heterochromatin and Contributes to Heterochromatin Maintenance in Drosophila melanogaster

Eberle, Andrea B., Jordán-Pla, Antonio, Gañez-Zapater, Antoni, Hessle, Viktoria, Silberberg, Gilad, von Euler, Anne, Silverstein, Rebecca A., Visa, Neus · 2015 · PLOS Genetics
Cited by 21

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

RNA surveillance factors are involved in heterochromatin regulation in yeast and plants, but less is known about the possible roles of ribonucleases in the heterochromatin of animal cells. Here we show that RRP6, one of the catalytic subunits of the exosome, is necessary for silencing heterochromatic repeats in the genome of Drosophila melanogaster. We show that a fraction of RRP6 is associated with heterochromatin, and the analysis of the RRP6 interaction network revealed physical links between RRP6 and the heterochromatin factors HP1a, SU(VAR)3-9 and RPD3. Moreover, genome-wide studies of RRP6 occupancy in cells depleted of SU(VAR)3-9 demonstrated that SU(VAR)3-9 contributes to the tethering of RRP6 to a subset of heterochromatic loci. Depletion of the exosome ribonucleases RRP6 and DIS3 stabilizes heterochromatic transcripts derived from transposons and repetitive sequences, and renders the heterochromatin less compact, as shown by micrococcal nuclease and proximity-ligation assays. Such depletion also increases the amount of HP1a bound to heterochromatic transcripts. Taken together, our results suggest that SU(VAR)3-9 targets RRP6 to a subset of heterochromatic loci where RRP6 degrades chromatin-associated non-coding RNAs in a process that is necessary to maintain the packaging of the heterochromatin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1005523

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 RRP6 is associated with heterochromatin in vivo. (A) Salivary gland polytene chromosomes immunostained with antibodies against RRP6 (green) and HP1a (red). The figure shows an overview micrograph. ch: chromocenter. (B) A detail showing a telomere stained with antibodies against RRP6 and HP1a, as in A. The fluorescence profile in the right part of the image shows the co-variation of both signals along the telomeric region. (C) A detail showing the chromocenter (ch) stained with antibodies against RRP6 and HP1a, as in A. (D) Co-localization of HP1a and RRP6 in dense chromatin in S2 cells analyzed by immuno-EM. An overview of a thin section through the nucleus of a cell is shown to the left. The bar represents 1 μm. A high-magnification micrograph shows co-localization of HP1a (12 nm gold) and RRP6 (6 nm gold) in the dense chromatin (Dc). The bar represents 100 nm. (E) The fractionation scheme used to isolate the different nuclear fractions in S2 cells: soluble (nucleoplasm), chromosomal RNP, and chromatin. (F) The distribution of HP1a, RPD3, and RRP6-V5 in the different nuclear fractions in S2 cells analyzed by Western blotting. The experiment was carried out in cells that expressed V5-tagged RRP6. Histone H3 was used as a control.
Fig 1 RRP6 is associated with heterochromatin in vivo. (A) Salivary gland polytene chromosomes immunostained with antibodies against RRP6 (green) and HP1a (red). The figure shows an overview micrograph. ch: chromocenter. (B) A detail showing a telomere stained with antibodies against RRP6 and HP1a, as in A. The fluorescence profile in the right part of the image shows the co-variation of both signals along the telomeric region. (C) A detail showing the chromocenter (ch) stained with antibodies against RRP6 and HP1a, as in A. (D) Co-localization of HP1a and RRP6 in dense chromatin in S2 cells analyzed by immuno-EM. An overview of a thin section through the nucleus of a cell is shown to the left. The bar represents 1 μm. A high-magnification micrograph shows co-localization of HP1a (12 nm gold) and RRP6 (6 nm gold) in the dense chromatin (Dc). The bar represents 100 nm. (E) The fractionation scheme used to isolate the different nuclear fractions in S2 cells: soluble (nucleoplasm), chromosomal RNP, and chromatin. (F) The distribution of HP1a, RPD3, and RRP6-V5 in the different nuclear fractions in S2 cells analyzed by Western blotting. The experiment was carried out in cells that expressed V5-tagged RRP6. Histone H3 was used as a control.CC BY · PubMed Central
Fig 2 LC/MS-MS revealed interactions between the exosome and heterochromatin factors. (A) Some of the proteins co-immunoprecipitated with RRP6-V5 in S2 cells. The complete list of interactors is provided in S1 Table. (B) Enrichment of GO terms corresponding to RRP6 interactors. (C) Co-immunoprecipitation experiment performed with nuclear extracts of S2 cells expressing V5-tagged RRP6 using the anti-V5 antibody. The starting material (input), the immunoprecipitated proteins (IP) and the negative control were separated by SDS-PAGE and analysed by Western blotting using antibodies against V5, RPD3, and HP1a, as indicated. The band corresponding to HP1a is indicated with an asterisk. The thick band below HP1a is the light chain of the anti-V5 antibody (apparent molecular mass approx. 20 kDa). (D) Reciprocal co-immunoprecipitation experiments were performed in the RRP6-V5 cells using endogenous antibodies against HP1a and RPD3, as indicated. The asterisk indicates HP1a. (E) Co-immunoprecipitation experiment conducted in S2 cells that expressed simultaneously HA-tagged SU(VAR)3-9 and V5-tagged RRP6 using the anti-HA antibody to pull down SU(VAR)3-9. The interaction with RRP6 was confirmed by western blotting.
Fig 2 LC/MS-MS revealed interactions between the exosome and heterochromatin factors. (A) Some of the proteins co-immunoprecipitated with RRP6-V5 in S2 cells. The complete list of interactors is provided in S1 Table. (B) Enrichment of GO terms corresponding to RRP6 interactors. (C) Co-immunoprecipitation experiment performed with nuclear extracts of S2 cells expressing V5-tagged RRP6 using the anti-V5 antibody. The starting material (input), the immunoprecipitated proteins (IP) and the negative control were separated by SDS-PAGE and analysed by Western blotting using antibodies against V5, RPD3, and HP1a, as indicated. The band corresponding to HP1a is indicated with an asterisk. The thick band below HP1a is the light chain of the anti-V5 antibody (apparent molecular mass approx. 20 kDa). (D) Reciprocal co-immunoprecipitation experiments were performed in the RRP6-V5 cells using endogenous antibodies against HP1a and RPD3, as indicated. The asterisk indicates HP1a. (E) Co-immunoprecipitation experiment conducted in S2 cells that expressed simultaneously HA-tagged SU(VAR)3-9 and V5-tagged RRP6 using the anti-HA antibody to pull down SU(VAR)3-9. The interaction with RRP6 was confirmed by western blotting.CC BY · PubMed Central
Fig 3 Genome-wide effects of RRP6 depletion on the transcriptome of S2 cells. The effects of RRP6 depletion on the steady-state expression levels were investigated by RNA-seq. Control experiments (GFP RNAi) were carried out in parallel and used as a reference. The expression levels in the control GFP cells and in RRP6-depleted cells expressed as reads per million (y-axis) are shown in green and orange, respectively. Genomic coordinates are indicated in the x-axis in B-C. (A) Pie diagram showing the effect of RRP6 depletion on the levels of different types of sequences, as indicated. (B) Examples of the effect of RRP6 depletion on the expression of repeat sequences. The upper and lower panels show subtelomeric regions of chromosome arms 2L and 3R, respectively, and the middle panel shows a region near the 2R centromere. (C) The effect of RRP6 depletion on the expression of selected transposon sequences. The genomic position of each sequence is indicated in the x-axis. (D) RNAi experiments were carried out to knock down RRP6 alone or RRP6 and DIS3 simultaneously. RNA was isolated and analysed by RT-qPCR using primer pairs designed to amplify selected sequences (the primer sequences are provided in the Supplementary Materials and Methods). The data was normalised to actin 5C RNA levels and expressed as a fold change compared to the levels observed in the GFP control. A protein-coding gene, Pgk, was analysed in parallel as a control. The histogram shows averages and standard deviations from three independent biological replicates. (E) ChIP experiments with antibodies against histone H3, H3K9ac, and H3K9me2 were carried out in untreated S2 cells to analyze the chromatin state of the selected genomic regions. Actin 5C was analyzed in parallel as a representative for euchromatin. The histogram shows averages and standard deviations from three independent biological replicates.
Fig 3 Genome-wide effects of RRP6 depletion on the transcriptome of S2 cells. The effects of RRP6 depletion on the steady-state expression levels were investigated by RNA-seq. Control experiments (GFP RNAi) were carried out in parallel and used as a reference. The expression levels in the control GFP cells and in RRP6-depleted cells expressed as reads per million (y-axis) are shown in green and orange, respectively. Genomic coordinates are indicated in the x-axis in B-C. (A) Pie diagram showing the effect of RRP6 depletion on the levels of different types of sequences, as indicated. (B) Examples of the effect of RRP6 depletion on the expression of repeat sequences. The upper and lower panels show subtelomeric regions of chromosome arms 2L and 3R, respectively, and the middle panel shows a region near the 2R centromere. (C) The effect of RRP6 depletion on the expression of selected transposon sequences. The genomic position of each sequence is indicated in the x-axis. (D) RNAi experiments were carried out to knock down RRP6 alone or RRP6 and DIS3 simultaneously. RNA was isolated and analysed by RT-qPCR using primer pairs designed to amplify selected sequences (the primer sequences are provided in the Supplementary Materials and Methods). The data was normalised to actin 5C RNA levels and expressed as a fold change compared to the levels observed in the GFP control. A protein-coding gene, Pgk, was analysed in parallel as a control. The histogram shows averages and standard deviations from three independent biological replicates. (E) ChIP experiments with antibodies against histone H3, H3K9ac, and H3K9me2 were carried out in untreated S2 cells to analyze the chromatin state of the selected genomic regions. Actin 5C was analyzed in parallel as a representative for euchromatin. The histogram shows averages and standard deviations from three independent biological replicates.CC BY · PubMed Central
Fig 4 Depletion of exosome ribonucleases alters the compaction of the heterochromatin and increases the levels of heterochromatin-associated transcripts. (A) S2 cells were depleted of RRP6 and DIS3. Total RNA levels and chromatin-associated RNA levels were calculated for two selected heterochromatin sequences and a protein-coding gene (Pgk) as control. The data was normalized to actin 5C and expressed as a fold change relative to the GFP control. The histogram shows averages and standard deviations of three independent biological replicates. (B) MNase assays were carried out in S2 cells depleted of RRP6 or depleted of both RRP6 and DIS3. The digested chromatin was quantified by qPRC and compared to the corresponding chromatin in undigested samples. The values were normalized to a nucleosome-free region in the Hsp70 promoter (Petesch and Lis, 2008). The histogram shows the average values expressed as a fold change relative to the GFP control (blue line) calculated from four (for RRP6 KD) and two (for RRP6+DIS3 KD) independent biological replicates, respectively. The error bars represent standard deviations. (C) IF analysis of S2 cells after knock-down of RRP6 and DIS3. The figure shows examples of cells stained with antibodies against HP1a and counterstained with DAPI. The bar represents 5 μm. (D) Quantification of chromatin patterns in cells stained as in C. Cells were classified as either showing few discrete fluorescent dots, or fragmented or diffuse staining. The stacked bars show the percentage of cells in each class. (E) PLA analysis with antibodies against HP1a and histone H3 were carried out in S2 cells depleted of both RRP6 and DIS3, and in control cells treated in parallel with GFP-dsRNA. The images show examples of PLA staining (magenta) in cells counterstained with DAPI (blue). The graph shows the number of PLA dots per cell in each condition. The mean number of dots per cell (magenta line) was 3,63 in GFP control cells and 1,96 in cells depleted of Rrp6 and Dis3. The difference was highly significant (P<0.0001; two-tailed Mann Whitney test; n = 140 cells analyzed in each condition, from two independent experiments). (F) RIP experiments with an antibody against HP1a were performed to quantify the binding of HP1a with chromatin-bound RNAs derived from selected heterochromatic regions in control cells and in cells depleted of RRP6 and DIS3. The RIP signals of the knockdowns are expressed as fold changes relative to the GFP control samples (blue line). Averages and standard deviations from two biological replicates, each with two technical replicates, are presented. Note that the signals of the GFP samples were near background levels (S8 Fig). (G) S2 cells depleted of HP1a were analysed as in A. The data was normalised to actin 5C. Averages and standard deviations of three independent biological replicates are presented in the histogram.
Fig 4 Depletion of exosome ribonucleases alters the compaction of the heterochromatin and increases the levels of heterochromatin-associated transcripts. (A) S2 cells were depleted of RRP6 and DIS3. Total RNA levels and chromatin-associated RNA levels were calculated for two selected heterochromatin sequences and a protein-coding gene (Pgk) as control. The data was normalized to actin 5C and expressed as a fold change relative to the GFP control. The histogram shows averages and standard deviations of three independent biological replicates. (B) MNase assays were carried out in S2 cells depleted of RRP6 or depleted of both RRP6 and DIS3. The digested chromatin was quantified by qPRC and compared to the corresponding chromatin in undigested samples. The values were normalized to a nucleosome-free region in the Hsp70 promoter (Petesch and Lis, 2008). The histogram shows the average values expressed as a fold change relative to the GFP control (blue line) calculated from four (for RRP6 KD) and two (for RRP6+DIS3 KD) independent biological replicates, respectively. The error bars represent standard deviations. (C) IF analysis of S2 cells after knock-down of RRP6 and DIS3. The figure shows examples of cells stained with antibodies against HP1a and counterstained with DAPI. The bar represents 5 μm. (D) Quantification of chromatin patterns in cells stained as in C. Cells were classified as either showing few discrete fluorescent dots, or fragmented or diffuse staining. The stacked bars show the percentage of cells in each class. (E) PLA analysis with antibodies against HP1a and histone H3 were carried out in S2 cells depleted of both RRP6 and DIS3, and in control cells treated in parallel with GFP-dsRNA. The images show examples of PLA staining (magenta) in cells counterstained with DAPI (blue). The graph shows the number of PLA dots per cell in each condition. The mean number of dots per cell (magenta line) was 3,63 in GFP control cells and 1,96 in cells depleted of Rrp6 and Dis3. The difference was highly significant (P<0.0001; two-tailed Mann Whitney test; n = 140 cells analyzed in each condition, from two independent experiments). (F) RIP experiments with an antibody against HP1a were performed to quantify the binding of HP1a with chromatin-bound RNAs derived from selected heterochromatic regions in control cells and in cells depleted of RRP6 and DIS3. The RIP signals of the knockdowns are expressed as fold changes relative to the GFP control samples (blue line). Averages and standard deviations from two biological replicates, each with two technical replicates, are presented. Note that the signals of the GFP samples were near background levels (S8 Fig). (G) S2 cells depleted of HP1a were analysed as in A. The data was normalised to actin 5C. Averages and standard deviations of three independent biological replicates are presented in the histogram.CC BY · PubMed Central
Fig 5 The catalytic activity of RRP6 is required for the silencing of transposon transcripts and for the maintenance of heterochromatin compaction. Wild-type RRP6-V5 or catalytically inactive mutants RRP6-Y361A-V5 and RRp6-D328A-V5 were expressed in S2 cells. Control cells that did not overexpress any protein were used in parallel for comparison. (A) Analysis of protein expression by Western blotting using an antibody against the V5 tag. Histone H3 served as loading control. (B) RT-qPCR analysis of transcript levels in cells that overexpress wither the wild-type RRP6-V5 or the catalytically inactive mutants. RNA was isolated and analyzed using primer pairs designed to amplify selected sequences, as indicated in the figure. The data was normalised to actin 5C mRNA levels and expressed as a fold change compared to the levels observed in the control cells (dark blue line). The histogram shows averages and standard deviations from three independent biological replicates. (C) PLA analysis of chromatin compaction using antibodies against HP1a and histone H3. The images show examples of PLA staining (magenta) in cells counterstained with DAPI (blue). The graph shows the number of PLA dots per cell in each condition. The mean number of dots per cell (magenta line) was 3,93 in the cells that overexpressed wild-type RRP6-V6 and 2,04 in cells that overexpressed RRP6-Y361A-V5. The difference was highly significant (P<0.0001; two-tailed Mann Whitney test; n = 150 cells analyzed in each condition, from two independent experiments).
Fig 5 The catalytic activity of RRP6 is required for the silencing of transposon transcripts and for the maintenance of heterochromatin compaction. Wild-type RRP6-V5 or catalytically inactive mutants RRP6-Y361A-V5 and RRp6-D328A-V5 were expressed in S2 cells. Control cells that did not overexpress any protein were used in parallel for comparison. (A) Analysis of protein expression by Western blotting using an antibody against the V5 tag. Histone H3 served as loading control. (B) RT-qPCR analysis of transcript levels in cells that overexpress wither the wild-type RRP6-V5 or the catalytically inactive mutants. RNA was isolated and analyzed using primer pairs designed to amplify selected sequences, as indicated in the figure. The data was normalised to actin 5C mRNA levels and expressed as a fold change compared to the levels observed in the control cells (dark blue line). The histogram shows averages and standard deviations from three independent biological replicates. (C) PLA analysis of chromatin compaction using antibodies against HP1a and histone H3. The images show examples of PLA staining (magenta) in cells counterstained with DAPI (blue). The graph shows the number of PLA dots per cell in each condition. The mean number of dots per cell (magenta line) was 3,93 in the cells that overexpressed wild-type RRP6-V6 and 2,04 in cells that overexpressed RRP6-Y361A-V5. The difference was highly significant (P<0.0001; two-tailed Mann Whitney test; n = 150 cells analyzed in each condition, from two independent experiments).CC BY · PubMed Central
Fig 6 SU(VAR)3-9 depletion affects the association of RRP6 with chromatin. The association of selected proteins with the chromatin was analyzed by Western blotting using native chromatin preparations fractionated according to the scheme in Fig 1F. (A) Analysis of S2 cells that express the HA-tagged SU(VAR)3-9. The global levels of HP1a and SU(VAR)3-9 in the chromatin were analyzed in control cells (GFP) and in cells depleted of RRP6 and DIS3, or HP1a. The chromatin fractions were analysed using different antibodies, as indicated in the figure. An anti-HA antibody was used to detect SU(VAR)3-9. H3 and H3K9me2 served as controls. (B) Analysis of S2 cells that express the V5-tagged RRP6 depleted of HP1a. An anti-V5 antibody was used to detect RRP6 in the chromatin fractions. Depletion of HP1a does not affect the levels of RRP6 bound to the chromatin fraction. (C) Analysis of S2 cells that express the V5-tagged RRP6 depleted of SU(VAR)3-9. An anti-V5 antibody was used to detect RRP6. The quantification of the band intensities from three independent experiments is shown to the right. The standard deviations are given in parentheses. Histone H3 was used for normalization.
Fig 6 SU(VAR)3-9 depletion affects the association of RRP6 with chromatin. The association of selected proteins with the chromatin was analyzed by Western blotting using native chromatin preparations fractionated according to the scheme in Fig 1F. (A) Analysis of S2 cells that express the HA-tagged SU(VAR)3-9. The global levels of HP1a and SU(VAR)3-9 in the chromatin were analyzed in control cells (GFP) and in cells depleted of RRP6 and DIS3, or HP1a. The chromatin fractions were analysed using different antibodies, as indicated in the figure. An anti-HA antibody was used to detect SU(VAR)3-9. H3 and H3K9me2 served as controls. (B) Analysis of S2 cells that express the V5-tagged RRP6 depleted of HP1a. An anti-V5 antibody was used to detect RRP6 in the chromatin fractions. Depletion of HP1a does not affect the levels of RRP6 bound to the chromatin fraction. (C) Analysis of S2 cells that express the V5-tagged RRP6 depleted of SU(VAR)3-9. An anti-V5 antibody was used to detect RRP6. The quantification of the band intensities from three independent experiments is shown to the right. The standard deviations are given in parentheses. Histone H3 was used for normalization.CC BY · PubMed Central
Fig 7 Depletion of SU(VAR)3-9 influences RRP6 genomic occupancy in S2 cells. ChIP-seq experiments were carried out using S2 cells that expressed V5-tagged RRP6 under low-induction conditions. Chromatin preparations from control GFP cells and from cells depleted of SU(VAR)3-9 were used for ChIP-seq using an anti-V5 antibody. (A) Pie diagram showing the association of RRP6-rich regions with different types of sequences in control cells. (B) Chromosome distribution of RRP6 expressed in control cells as percentage of RRP6-rich regions in each chromosome (green bars). Two different scales are shown due to the lower fraction of regions in the heterochromatic scaffolds compared to the rest of the chromosome arms. The grey bars indicate the fraction of the genome corresponding to each chromosome, for comparison. (C) Depletion of SU-VAR)3-9 affects RRP6 genomic occupancy. For each chromosome or scaffold, the number of RRP6-rich regions upregulated or downregulated is expressed as percentage of the number of changed regions relative to the number of regions in that same chromosome in control cells. The percentage of affected regions is much higher in heterochromatin. (D) RRP6 occupancy in the genomic regions analyzed in Fig 4. The arrows indicate the regions amplified in the qPCR assays.
Fig 7 Depletion of SU(VAR)3-9 influences RRP6 genomic occupancy in S2 cells. ChIP-seq experiments were carried out using S2 cells that expressed V5-tagged RRP6 under low-induction conditions. Chromatin preparations from control GFP cells and from cells depleted of SU(VAR)3-9 were used for ChIP-seq using an anti-V5 antibody. (A) Pie diagram showing the association of RRP6-rich regions with different types of sequences in control cells. (B) Chromosome distribution of RRP6 expressed in control cells as percentage of RRP6-rich regions in each chromosome (green bars). Two different scales are shown due to the lower fraction of regions in the heterochromatic scaffolds compared to the rest of the chromosome arms. The grey bars indicate the fraction of the genome corresponding to each chromosome, for comparison. (C) Depletion of SU-VAR)3-9 affects RRP6 genomic occupancy. For each chromosome or scaffold, the number of RRP6-rich regions upregulated or downregulated is expressed as percentage of the number of changed regions relative to the number of regions in that same chromosome in control cells. The percentage of affected regions is much higher in heterochromatin. (D) RRP6 occupancy in the genomic regions analyzed in Fig 4. The arrows indicate the regions amplified in the qPCR assays.CC BY · PubMed Central
Fig 8 A model for the role of RRP6 in the maintenance of heterochromatin packaging. Heterochromatin domains are characterized by high levels of H3K9me2 and by the presence of HP1a and SU(VAR)3-9. Our results show that RRP6 interacts with SU(VAR)3-9 and that this interaction is important to tether RRP6 to the heterochromatin. Transcripts derived from sporadic transcription of heterochromatic repeat sequences are kept at low levels by RRP6 degradation. Failure to degrade such transcripts results in increased levels of chromatin-associated transcripts, increased binding of HP1 to the chromatin-associated transcripts, and chromatin decondensation.
Fig 8 A model for the role of RRP6 in the maintenance of heterochromatin packaging. Heterochromatin domains are characterized by high levels of H3K9me2 and by the presence of HP1a and SU(VAR)3-9. Our results show that RRP6 interacts with SU(VAR)3-9 and that this interaction is important to tether RRP6 to the heterochromatin. Transcripts derived from sporadic transcription of heterochromatic repeat sequences are kept at low levels by RRP6 degradation. Failure to degrade such transcripts results in increased levels of chromatin-associated transcripts, increased binding of HP1 to the chromatin-associated transcripts, and chromatin decondensation.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 51

  1. Hoskins R.A., Carlson J.W., Kennedy C., Acevedo D., Evans-Holm M., et al (2007). Sequence finishing and mapping of Drosophila melanogaster heterochromatin. Science 316, 1625– 1628. 17569867 PMC2825053 · DOI · Paper page
  2. Lucchesi J.C. (2011). Drosophila Epigenetics In: Handbook of Epigenetics: The New Molecular and Medical Genetics. Elsevier Inc, 203– 232.
  3. Grewal S.I., and Elgin S.C. (2007). Transcription and RNA interference in the formation of heterochromatin. Nature 447, 399– 406. 17522672 PMC2950806 · DOI · Paper page
  4. Lachner M., O'Carroll D., Rea S., Mechtler K., and Jenuwein T. (2001). Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116– 120. 11242053 · DOI · Paper page
  5. Piacentini L., Fanti L., Negri R., Del Vescovo V., Fatica A., et al (2009). Heterochromatin protein 1 (HP1a) positively regulates euchromatic gene expression through RNA transcript association and interaction with hnRNPs in Drosophila. PLoS genetics 5, e1000670 10.1371/journal.pgen.1000670 19798443 PMC2743825 · DOI · Paper page
  6. Keller C., Adaixo R., Stunnenberg R., Woolcock K.J., Hiller S., et al (2012). HP1(Swi6) mediates the recognition and destruction of heterochromatic RNA transcripts. Molecular cell 47, 215– 227. 10.1016/j.molcel.2012.05.009 22683269 · DOI
  7. Castel S.E., and Martienssen R.A. (2013). RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond. Nat Rev Genet 14, 100– 112. 10.1038/nrg3355 23329111 PMC4205957 · DOI · Paper page
  8. Bühler M., Verdel A., and Moazed D. (2006). Tethering RITS to a nascent transcript initiates RNAi- and heterochromatin-dependent gene silencing. Cell 125, 873– 886. 16751098 · DOI · Paper page
  9. Zhang H., and Zhu J.K. (2011). RNA-directed DNA methylation. Curr Opin Plant Biol 14, 142– 147. 10.1016/j.pbi.2011.02.003 21420348 PMC3096526 · DOI · Paper page
  10. Lin H., and Yin H. (2008). A novel epigenetic mechanism in Drosophila somatic cells mediated by Piwi and piRNAs. Cold Spring Harb Symp Quant Biol 73, 273– 281. 10.1101/sqb.2008.73.056 19270080 PMC2810500 · DOI · Paper page
  11. Huang X.A., Yin H., Sweeney S., Raha D., Snyder M., et al (2013). A major epigenetic programming mechanism guided by piRNAs. Dev Cell 24, 502– 516. 10.1016/j.devcel.2013.01.023 23434410 PMC3600162 · DOI · Paper page
  12. Le Thomas A., Rogers A.K., Webster A., Marinov G.K., Liao S.E., et al (2013). Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state. Genes Dev. 27, 390– 399. 10.1101/gad.209841.112 23392610 PMC3589556 · DOI · Paper page
  13. Rozhkov N.V., Hammell M., and Hannon G.J. (2013). Multiple roles for Piwi in silencing Drosophila transposons. Genes Dev. 27, 400– 412. 10.1101/gad.209767.112 23392609 PMC3589557 · DOI · Paper page
  14. Sentmanat M.F., and Elgin S.C. (2012). Ectopic assembly of heterochromatin in Drosophila melanogaster triggered by transposable elements. Proceedings of the National Academy of Sciences of the United States of America 109, 14104– 14109. 10.1073/pnas.1207036109 22891327 PMC3435190 · DOI · Paper page
  15. Gu T., and Elgin S.C. (2013). Maternal depletion of Piwi, a component of the RNAi system, impacts heterochromatin formation in Drosophila. PLoS genetics 9, e1003780 10.1371/journal.pgen.1003780 24068954 PMC3777992 · DOI
  16. Houseley J., LaCava J., and Tollervey D. (2006). RNA-quality control by the exosome. Nat Rev Mol Cell Biol 7, 529– 539. 16829983 · DOI · Paper page
  17. Lykke-Andersen S., Tomecki R., Jensen T.H., and Dziembowski A. (2011). The eukaryotic RNA exosome: same scaffold but variable catalytic subunits. RNA Biol 8, 61– 66. 21289487 · DOI · Paper page
  18. Chlebowski A., Lubas M., Jensen T.H., and Dziembowski A. (2013). RNA decay machines: the exosome. Biochimica et biophysica acta 1829, 552– 560. 10.1016/j.bbagrm.2013.01.006 23352926 · DOI · Paper page
  19. Andrulis E.D., Werner J., Nazarian A., Erdjument-Bromage H., Tempst P., et al (2002). The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila. Nature 420, 837– 841. 12490954 · DOI · Paper page
  20. Schmid M., and Jensen T.H. (2008). The exosome: a multipurpose RNA-decay machine. Trends in biochemical sciences 33, 501– 510. 10.1016/j.tibs.2008.07.003 18786828 · DOI · Paper page
  21. Eberle A. B. and Visa N. (2014). Quality control of mRNP biogenesis: networking at the transcription site. Semin Cell Dev Biol 32: 37– 46. 10.1016/j.semcdb.2014.03.033 24713468 · DOI
  22. Wyers F., Rougemaille M., Badis G., Rousselle J.C., Dufour M.E., et al (2005). Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase. Cell 121, 725– 737. 15935759 · DOI · Paper page
  23. Chekanova J.A., Gregory B.D., Reverdatto S.V., Chen H., Kumar R., et al (2007). Genome-wide high-resolution mapping of exosome substrates reveals hidden features in the Arabidopsis transcriptome. Cell 131, 1340– 1353. 18160042 · DOI · Paper page
  24. Preker P., Nielsen J., Kammler S., Lykke-Andersen S., Christensen M.S., et al (2008). RNA exosome depletion reveals transcription upstream of active human promoters. Science 322, 1851– 1854. 10.1126/science.1164096 19056938 · DOI · Paper page
  25. Seila A.C., Calabrese J.M., Levine S.S., Yeo G.W., Rahl P.B., et al (2008). Divergent transcription from active promoters. Science 322, 1849– 1851. 10.1126/science.1162253 19056940 PMC2692996 · DOI · Paper page
  26. Marin-Vicente C., Domingo-Prim J., Eberle A.B., Visa N. (2015). RRP6/EXOSC10 is required for the repair of DNA double-strand breaks by homologous recombination. J Cell Sci. 128, 1097– 1107. 10.1242/jcs.158733 25632158 · DOI · Paper page
  27. Reyes-Turcu F.E., and Grewal S.I. (2012). Different means, same end-heterochromatin formation by RNAi and RNAi-independent RNA processing factors in fission yeast. Curr Opin Genet Dev 22, 156– 163. 10.1016/j.gde.2011.12.004 22243696 PMC3331891 · DOI · Paper page
  28. Reyes-Turcu F.E., Zhang K., Zofall M., Chen E., and Grewal S.I. (2011). Defects in RNA quality control factors reveal RNAi-independent nucleation of heterochromatin. Nature structural & molecular biology 18, 1132– 1138. PMC3190054 21892171 · DOI · Paper page
  29. Yamanaka S., Mehta S., Reyes-Turcu F.E., Zhuang F., Fuchs R.T., et al (2013) RNAi triggered by specialized machinery silences developmental genes and retrotransposons. Nature 493, 557– 560. 10.1038/nature11716 23151475 PMC3554839 · DOI · Paper page
  30. Hessle V., von Euler A., Gonzalez de Valdivia E., and Visa N. (2012). Rrp6 is recruited to transcribed genes and accompanies the spliced mRNA to the nuclear pore. RNA 18, 1466– 1474. 10.1261/rna.032045.111 22745224 PMC3404368 · DOI · Paper page
  31. Tyagi A., Ryme J., Brodin D., Ostlund Farrants A.K., and Visa N. (2009). SWI/SNF associates with nascent pre-mRNPs and regulates alternative pre-mRNA processing. PLoS Genetics 5, e1000470 10.1371/journal.pgen.1000470 19424417 PMC2669885 · DOI
  32. Hessle V., Bjork P., Sokolowski M., Gonzalez de Valdivia E., Silverstein R., et al (2009). The exosome associates cotranscriptionally with the nascent pre-mRNP through interactions with heterogeneous nuclear ribonucleoproteins. Molecular biology of the cell 20, 3459– 3470. 10.1091/mbc.E09-01-0079 19494042 PMC2719564 · DOI
  33. Lim S.J., Boyle P.J., Chinen M., Dale R.K., and Lei E.P. (2013). Genome-wide localization of exosome components to active promoters and chromatin insulators in Drosophila. Nucleic acids research 41, 2963– 2980. 10.1093/nar/gkt037 23358822 PMC3597698 · DOI · Paper page
  34. Kiss D.L., and Andrulis E.D. (2010). Genome-wide analysis reveals distinct substrate specificities of Rrp6, Dis3, and core exosome subunits. RNA 16, 781– 791. 10.1261/rna.1906710 20185544 PMC2844625 · DOI · Paper page
  35. Graham A.C., Kiss D.L., Andrulis E.D. (2009). Core exosome-independent roles for Rrp6 in cell cycle progression. Mol Biol Cell 20, 2242– 2253. 10.1091/mbc.E08-08-0825 19225159 PMC2669031 · DOI
  36. Filion G.J., van Bemmel J.G., Braunschweig U., Talhout W., Kind J., et al (2010). Systematic protein location mapping reveals five principal chromatin types in Drosophila cells. Cell 143, 212– 224. 10.1016/j.cell.2010.09.009 20888037 PMC3119929 · DOI · Paper page
  37. Petesch S.J., and Lis J.T. (2008). Rapid, transcription-independent loss of nucleosomes over a large chromatin domain at Hsp70 loci. Cell 134, 74– 84. 10.1016/j.cell.2008.05.029 18614012 PMC2527511 · DOI · Paper page
  38. Phillips S. and Butler J. S. (2003). Contribution of domain structure to the RNA 3' end processing and degradation functions of the nuclear exosome subunit Rrp6p. RNA. 9, 1098– 1107. 12923258 PMC1370474
  39. Mendjan S., Taipale M., Kind J., Holz H., Gebhardt P., et al (2006). Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosphila. Mol Cell 21, 811– 23 16543150 · DOI · Paper page
  40. Yin H., and Lin H. (2007). An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster. Nature 450: 304– 308. 17952056 · DOI · Paper page
  41. Richards E.J., and Elgin S.C. (2002). Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108, 489– 500. 11909520 · DOI · Paper page
  42. Kiss D.L., and Andrulis E.D. (2011). The exozyme model: a continuum of functionally distinct complexes. RNA 17, 1– 13. 10.1261/rna.2364811 21068185 PMC3004051 · DOI
  43. Bühler M., Spies N., Bartel D.P., and Moazed D. (2008). TRAMP-mediated RNA surveillance prevents spurious entry of RNAs into the Schizosaccharomyces pombe siRNA pathway. Nature structural & Molecular biology 15, 1015– 1023. PMC3240669 18776903 · DOI · Paper page
  44. Keller C., Kulasegaran-Shylini R., Shimada Y., Hotz H.R., and Bühler M. (2013). Noncoding RNAs prevent spreading of a repressive histone mark. Nature structural & molecular biology 20, 1340. 24197168 · doi:10.1038/nsmb1113-1340
  45. Lubas M., Christensen M.S., Kristiansen M.S., Domanski M., Falkenby L.G., et al (2011). Interaction profiling identifies the human nuclear exosome targeting complex. Mol Cell 43, 624– 37. 10.1016/j.molcel.2011.06.028 21855801 · DOI · Paper page
  46. Andersen P. R., Domanski M., Kristiansen M. S., Storvall H., Ntini E., et al (2013). The human cap-binding complex is functionally connected to the nuclear RNA exosome. Nat Struct Mol Biol 20: 1367– 76. 10.1038/nsmb.2703 24270879 PMC3923317 · DOI · Paper page
  47. Huang da W., Sherman B.T., and Lempicki R.A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44– 57. 10.1038/nprot.2008.211 19131956 · DOI · Paper page
  48. Eberle A.B., Hessle V., Helbig R., Dantoft W., Gimber N., et al (2010). Splice-site mutations cause Rrp6-mediated nuclear retention of the unspliced RNAs and transcriptional down-regulation of the splicing-defective genes. PLoS One 5, e11540 10.1371/journal.pone.0011540 20634951 PMC2902512 · DOI
  49. Kim D., Pertea G., Trapnell C., Pimentel H., Kelley R., et al (2013). TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14(4), R36 10.1186/gb-2013-14-4-r36 23618408 PMC4053844 · DOI · Paper page
  50. Robinson J. T., Thorvaldsdóttir H., Winckler W., Guttman M., Lander E. S., et al (2011) Integrative Genomics Viewer. Nature Biotechnology 29, 24– 26. 10.1038/nbt.1754 21221095 PMC3346182 · DOI · Paper page
  51. Eberle A.B., Bohm S., Ostlund Farrants A.K., and Visa N. (2012). The use of a synthetic DNA-antibody complex as external reference for chromatin immunoprecipitation. Anal Biochem 426, 147– 152. 10.1016/j.ab.2012.04.020 22543092 · DOI

Cited by

Metadata

Authors
Eberle, A. B., Jordán-Pla, A., Gañez-Zapater, A., Hessle, V., Silberberg, G., von Euler, A., Silverstein, R. A., & Visa, N.
Venue
PLOS Genetics
Published
2015-09-21
Volume
11
Issue
9
Pages
e1005523
ISSN
1553-7404
Cited by
21
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.